EUVIMEDSkopri EUVIMED
MetaanalyseSystematische ÜbersichtOpen access · CC BY 4.0

Meta‐Analysis: Chronic Gastrointestinal Symptoms and Comorbidities in Hypermobile Ehlers–Danlos Syndrome and Hypermobility Spectrum Disorders

Dmitrii Kulin, Gerald Holtmann, Thomas Fairlie, Kyle Staller iD, Samuel Nurko iD, Laurie Keefer iD, Douglas A Drossman, Michael P Jones iD, Qasim Aziz, Ayesha Shah iD

Alimentary Pharmacology & Therapeutics · 2026

DOI: 10.1111/apt.70856 ↗

At a glance

Metaanalyse in Alimentary Pharmacology & Therapeutics, 2026. Written by Dmitrii Kulin and 9 co-authors. Institution: Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia. Major MEDLINE topics: Ehlers-Danlos Syndrome, Gastrointestinal Diseases, Joint Instability. Cited 1 times so far (Crossref); 47 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Health and Medical Research Council, NHMRC CRE in Transforming Gut Health.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Patients with Ehlers–Danlos syndrome (EDS)/hypermobility spectrum disorders (HSD) report higher rates of chronic gastrointestinal (GI) symptoms, disorders of gut–brain interaction (DGBI), and extraintestinal comorbidities.

Aims

We conducted a systematic review and meta‐analysis to assess the prevalence of chronic GI symptoms and comorbid conditions in hEDS/HSD.

Methods

Electronic databases were searched until December 2025 for studies reporting on chronic GI symptoms in hEDS/HSD patients. Pooled prevalence rates, odds ratios (ORs), and 95% confidence intervals (CIs) were calculated using the random effects model.

Results

The final dataset of 19 studies included 17,455 hEDS/HSD patients and 1,677,465 controls. The odds of chronic GI symptoms were higher in patients with hEDS/HSD compared to controls (OR 4.29, 95% CI 3.1–6.0). 65.3% (95% CI 51.4–77.0) of hEDS/HSD patients reported at least one chronic GI symptom, with heartburn being the most common (34.7%, 95% CI 28.3–41.7). The prevalence of DGBI in hEDS/HSD patients was 44.2% (95% CI 23.9–66.6), with functional dysphagia the most common DGBI at 34.2% (95% CI 25.7–43.8). Gastroesophageal reflux disease was reported in 41.3% (95% CI 27.2–57.0). In hEDS/HSD patients, the most common extraintestinal comorbidity was chronic fatigue (49%, 95% CI 34.6–63.6), followed by migraine (38.2%, 95% CI 19.9–60.5), orthostatic intolerance (OI) (35.9%, 95% CI 26.6–46.4), fibromyalgia (27.9%, 95% CI 16.0–44.0) and postural orthostatic tachycardia syndrome (POTS) (21.9%, 95% CI 5.2–59.1).

Conclusions

Overall, > 60% of hEDS/HSD patients report chronic GI symptoms. DGBI, co‐morbidities, including POTS, were highly prevalent in hEDS/HSD patients. However, the quality of the evidence is low due to significant clinical heterogeneity observed in the analyses. While the associations may suggest a causal relationship, the results should be interpreted with caution.

Subjects

MeSH terms (MEDLINE)

Ehlers-Danlos SyndromeGastrointestinal DiseasesJoint InstabilityHumansComorbidityChronic DiseasePrevalence

Author keywords

Ehlers–Danlos syndromegastrointestinal symptomshypermobility spectrum disorderssystematic review and meta‐analysis

Authors and institutions

  • Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
  • Translational Research Institute, Brisbane, Queensland, Australia.
  • Department of Gastroenterology & Hepatology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
  • Centre for Neurointestinal Health, Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.
  • Centre for Motility and Functional Gastrointestinal Disorders, Boston Children's Hospital, Boston, Massachusetts, USA.

ORCID profiles: Kyle Staller, Samuel Nurko, Laurie Keefer, Michael P Jones, Ayesha Shah

Funding

  • National Health and Medical Research Council
  • NHMRC CRE in Transforming Gut Health

Cite

APA

Kulin, D., Holtmann, G., Fairlie, T., Staller, K., Nurko, S., Keefer, L., Drossman, D. A., Jones, M. P., Aziz, Q., & Shah, A. (2026). Meta‐Analysis: Chronic Gastrointestinal Symptoms and Comorbidities in Hypermobile Ehlers–Danlos Syndrome and Hypermobility Spectrum Disorders. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70856

Vancouver

Kulin D, Holtmann G, Fairlie T, Staller K, Nurko S, Keefer L, et al. Meta‐Analysis: Chronic Gastrointestinal Symptoms and Comorbidities in Hypermobile Ehlers–Danlos Syndrome and Hypermobility Spectrum Disorders. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.70856

BibTeX
@article{Kulin2026,
  author = {Kulin, Dmitrii and Holtmann, Gerald and Fairlie, Thomas and Staller, Kyle and Nurko, Samuel and Keefer, Laurie and Drossman, Douglas A and Jones, Michael P and Aziz, Qasim and Shah, Ayesha},
  title = {Meta‐Analysis: Chronic Gastrointestinal Symptoms and Comorbidities in Hypermobile Ehlers–Danlos Syndrome and Hypermobility Spectrum Disorders},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1111/apt.70856}
}
Start for free →